- Home
- BBCQ vs SOPH Comparison
BBCQ vs SOPH Comparison
Compare BBCQ & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBCQ | SOPH |
|---|---|---|
| Founded | 2025 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 395.6M | 462.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BBCQ | SOPH |
|---|---|---|
| Price | $10.23 | $6.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 109.2K | ★ 347.2K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.92 | $2.97 |
| 52 Week High | $11.26 | $6.98 |
Technical Indicators
Market Signals| Indicator | BBCQ | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | N/A |
| Support Level | $10.17 | N/A |
| Resistance Level | $10.38 | N/A |
| Average True Range (ATR) | 0.05 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 26.09 | 0.00 |
Price Performance
Historical ComparisonAbout BBCQ Bleichroeder Acquisition Corp. II Class A Ordinary Shares
Bleichroeder Acquisition Corp II is a blank check company incorporated. The company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the company has not yet identified.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.